Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-29 @ 5:08 AM
Study NCT ID:
NCT04880850
Status:
COMPLETED
Last Update Posted:
2025-12-04
First Post:
2021-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)
Sponsor:
Novo Nordisk A/S
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NN1436-4480
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None